These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Overexpression of CD200 and CD123 is a major influential factor in the clinical course of pediatric acute myeloid leukemia. Kandeel EZ, Madney Y, Eldin DN, Shafik NF. Exp Mol Pathol; 2021 Feb; 118():104597. PubMed ID: 33358743 [Abstract] [Full Text] [Related]
5. CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group. Lamble AJ, Eidenschink Brodersen L, Alonzo TA, Wang J, Pardo L, Sung L, Cooper TM, Kolb EA, Aplenc R, Tasian SK, Loken MR, Meshinchi S. J Clin Oncol; 2022 Jan 20; 40(3):252-261. PubMed ID: 34855461 [Abstract] [Full Text] [Related]
6. Clinical value of CD25/CD123 co-expression in acute myeloid leukemia patients. Aref S, Azmy E, El Ghannam D, Haroun M, Ibrahim L, Sabry M. Cancer Biomark; 2020 Jan 20; 29(1):9-16. PubMed ID: 32417762 [Abstract] [Full Text] [Related]
7. CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection. Al-Mawali A, Pinto AD, Al-Zadjali S. Acta Haematol; 2017 Jan 20; 138(3):175-181. PubMed ID: 29065396 [Abstract] [Full Text] [Related]
15. Expression of CD123 Related Long Non-coding RNA in Acute Myeloid Leukemia Bone Marrow Mononuclear Cells and Its Clinical Significance. Feng Y, Su B, Xu Y, He Y, He R, Ge F. Cell Mol Biol (Noisy-le-grand); 2022 Jun 30; 68(6):140-147. PubMed ID: 36227664 [Abstract] [Full Text] [Related]
16. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones. Al-Mawali A, Gillis D, Lewis I. J Hematol Oncol; 2016 Jul 27; 9(1):61. PubMed ID: 27465508 [Abstract] [Full Text] [Related]
17. Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia. Arai N, Homma M, Abe M, Baba Y, Murai S, Watanuki M, Kawaguchi Y, Fujiwara S, Kabasawa N, Tsukamoto H, Uto Y, Ariizumi H, Yanagisawa K, Hattori N, Saito B, Shiozawa E, Harada H, Yamochi-Onizuka T, Nakamaki T, Takimoto M. Int J Hematol; 2019 May 27; 109(5):539-544. PubMed ID: 30847774 [Abstract] [Full Text] [Related]
18. [Expression of CD25 in Acute Myeloid Leukemia Is An Adverse Prognostic Factor Independent of the Chromosome Karyotype]. Liu YF, Dong L, Wang C, Sun H, Zhang QT, Wang M, Li T, Xu Y, Ma J, Xie XS, Sun L, Wan DM. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr 27; 24(2):332-5. PubMed ID: 27150987 [Abstract] [Full Text] [Related]
19. Effect of Compound Zhebei Granule () combined with chemotherapy on surface markers of leukemia stem cell in patients with acute myeloid leukemia. Wang J, Lai ZL, Chen XY, Li DY, Zhang YY, Ma W, Chu YT, Shi FQ, Yang L, Hou L. Chin J Integr Med; 2016 Jun 27; 22(6):438-44. PubMed ID: 26666761 [Abstract] [Full Text] [Related]
20. [Characteristics and Prognosis of 24 Cases of Primary Acute Myeloid Leukemia with Trisomy 8]. Wang JH, Yao B, Guo M, Qiao JH, Sun QY, Hu KX, Li BX, Yu CL. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun 27; 24(3):655-61. PubMed ID: 27342486 [Abstract] [Full Text] [Related] Page: [Next] [New Search]